Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Letter. Sonbol MB, Halfdanarson TR. Clin Cancer Res 2020;26:2433.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sonbol MB, Halfdanarson TR. Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Letter. Clin Cancer Res 2020;26:2433.
PMID: 32414760